Ergotism: Difference between revisions
Ostermayer (talk | contribs) (Text replacement - "Category:Tox" to "Category:Toxicology") |
Neil.m.young (talk | contribs) (Text replacement - "==Sources==" to "==References==") |
||
| Line 48: | Line 48: | ||
==External Links== | ==External Links== | ||
== | ==References== | ||
<references/> | <references/> | ||
Goldfrank"s Toxicologic Emergencies, 9th Ed. Pgs 705-706, 763-769, and 1060-1064. | Goldfrank"s Toxicologic Emergencies, 9th Ed. Pgs 705-706, 763-769, and 1060-1064. | ||
[[Category:Toxicology]] | [[Category:Toxicology]] | ||
Revision as of 09:01, 27 June 2016
Background
- Long term effects of ergotamine usage or ergot poisoning
- Coadministration of ergotamine medication with triptan or certain abx
- Increase in serotonin activity
- Alpha-adrenergic agonist activity peripherally
Clinical Features
- Usage of ergotamines such as dihydroergotamine (DHE) and methylergometrine (Methergine)
- Miosis
- Burning sensation in extremities
- Cerebrovascular ischemia
- Seizures
- Cardiac ischemia
- GI disturbances
- Peripheral ischemia
Differential Diagnosis
- Atypical migraine
- CVA
Workup
Management
- Intake within 2 hours
- Considered activated charcoal
- Consider definitive airway
- Mild ergotism
- IVF
- Antiemetic
- Analgesia
- Severe Peripheral Vasoconstriction or Ischemia
- Vasodilators - nitroprusside, nitroglycerine
- Consider corticosteroids
- Consider heparinization
Disposition
- Consider obs for mild ergotism
- Admission for severe ergotism
See Also
External Links
References
Goldfrank"s Toxicologic Emergencies, 9th Ed. Pgs 705-706, 763-769, and 1060-1064.